Methods of treating sensorineural hearing loss using fibroblast growth factor 2 (FGF2)

Methods of using Fibroblast growth factor 2 (FGF2) to treat subjects with hearing loss associated with impaired word recognition.

Saved in:
Bibliographic Details
Main Authors Stankovic, Konstantina, Welling, Brad, Atai, Nadia A, Seist, Richard
Format Patent
LanguageEnglish
Published 19.08.2025
Subjects
Online AccessGet full text

Cover

More Information
Summary:Methods of using Fibroblast growth factor 2 (FGF2) to treat subjects with hearing loss associated with impaired word recognition.
Bibliography:Application Number: US202017614845